Selectquote Inc Stock Price, News & Analysis

Summary not available.

Summary not available.

SelectQuote, Inc. (NYSE: SLQT) is set to release its fiscal third quarter 2023 financial results on May 11, 2023, before market opening. CEO Tim Danker and CFO Ryan Clement will conduct a conference call at 8:30 am ET to discuss these results. The call will be accessible via registration, with an invitation sent to participants via email.

Founded in 1985, SelectQuote specializes in providing Medicare insurance policies and operates a Healthcare Services platform. The company's services span several domains, including Medicare, Pharmacy, and Value-Based Care, aiming to enhance health outcomes and reduce healthcare costs. It has established four primary business lines: Senior, Healthcare Services, Life, and Auto and Home.

SelectQuote, Inc. (NYSE: SLQT) has regained compliance with the New York Stock Exchange’s minimum stock price requirement as of February 28, 2023. The company received a notice on March 1, 2023, confirming that its average share price exceeded $1.00, addressing a previous deficiency communicated on October 20, 2022. While there are no immediate plans for a reverse stock split, the company will seek shareholder approval for a proposal that allows the Board to effect a reverse split in the future if deemed necessary. A special meeting for stockholders is scheduled for March 2, 2023.

SelectQuote, Inc. (NYSE: SLQT), a distributor of Medicare insurance policies, announced that CEO Tim Danker, President Bob Grant, and CFO Ryan Clement will participate in Citi’s 2023 Healthcare Conference on March 2, 2023, at 1:15 PM ET in New York City. Management will engage in a fireside chat and will be accessible for one-on-one and small group investor meetings. This event will be webcast live; details can be found on SelectQuote's Investor Relations website. Founded in 1985, SelectQuote offers insurance solutions through its highly-trained agents and proprietary technology, focusing on Medicare, Pharmacy, and Value-Based Care services.

SelectQuote (NYSE: SLQT) has appointed Ryan Clement as Chief Financial Officer, effective immediately. Clement, who served as Interim CFO since May 2022, was previously the SVP of Financial Planning & Analysis. CEO Tim Danker praised Clement’s financial expertise and leadership, noting his critical role in enhancing the company's financial stability. Clement expressed confidence in the company’s strategy, emphasizing a focus on profitability and cash flow. SelectQuote operates across several business lines, including insurance and healthcare services, supporting millions of Americans in managing their health and property.

SelectQuote reported a strong second quarter for fiscal 2023 with consolidated revenue of $319.2 million, up from $194.2 million the previous year. The company posted a net income of $22.5 million, compared to a net loss of $137.6 million in Q2 2022. Adjusted EBITDA reached $63.6 million, a significant recovery from $(164.0 million) in the prior year. The Senior segment contributed $223.8 million in revenue, while Healthcare Services had $55.5 million despite a negative EBITDA of $(9.3 million). SelectQuote has updated its fiscal year guidance, expecting revenue between $910 million and $960 million with a net loss range of $94 million to $78 million.

SelectQuote (NYSE: SLQT) will release its fiscal Q2 2023 financial results on February 7, 2023, prior to market open. CEO Tim Danker and interim CFO Ryan Clement will host a conference call at 8:30 am ET on the same day to discuss these results. The company specializes in unbiased insurance price comparisons, helping consumers secure suitable policies. SelectQuote serves diverse markets including Medicare and Value-Based Care through its four core business lines. This upcoming report is expected to provide insights into financial performance and future outlook.

SelectQuote, Inc. (NYSE: SLQT) announced preliminary financial results for Q2 FY2023, estimating revenue between $300 million to $320 million and net income of $11 million to $23 million. Full-year guidance now expects revenue of $890 million to $960 million, with a reduced net loss forecast of $98 million to $78 million. CEO Tim Danker attributed the positive results to improved performance in Medicare distribution and strategic enhancements in agent hiring and marketing efficiency.